Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who wrote (3474)	12/30/1997 4:18:00 PM
From: Miljenko Zuanic	Read Replies (2) of 6136

Sustiva has nothing to do with Viracept sales unless Merck can prove that Crix/Sustiva combination is better than any other triple or higher combination. Which they can because Sustiva has also resistance problems as any other RT dug. Your source of info is as well uninformed as you are. Also, Sustiva has its own competitiors. mz

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next